Hematopoietic cell phosphatase (HCP), encoded by the hcph gene, (also called PTPIC, SHP, SH-PTP1, and PTPN6) is deficient in motheaten (me~me), and the allelic viable motheaten (meV/ me ~) mice. Since HCP is expressed in many cell types and protein phosphorylation is a major mechanism of regulating protein function, it is not surprising that the motheaten phenotype is pleiotropic. It is commonly thought that immune system involvement causes this disease. If so, the motheaten disease ought to be alleviated when the recombination activation gene-1 (RAG-1) is disrupted because there will be no V(D)J rearrangement and thus impaired development of B and T cells. We bred homozygous, double-mutant meV/meV'RAG -1 -/-mice and found that, in fact, they developed full-blown motheaten inflammatory disease, including pneumonitis, alopecia, inflamed paws, and splenomegaly with elevated myelopoiesis. Thus, except for autoantibodies, the motheaten phenotype does not depend on the presence of B and T cells. This observation cautions the use of motheaten mice as a model of autoimmune disease. p rotein tyrosine kinases and phosphatases play a major role in protein tyrosine phosphorylation, a process that regulates cell growth and proliferation. Some understanding of the physiological role of particular protein kinases and phosphatases can be inferred from the phenotype of mutant animals. In the case of hematopoietic cell phosphatase (HCP) l (1-5), which is deficient in mice homozygous for the motheaten (me~me) mutations (6--8), the mutant phenotypes have been intensively studied. The me~me mice and the allelic me"/me ~ mice are severely immunodeficient. In both motheaten mutants, maturations of B and T lymphocytes are impaired. Both me~me and viable motheaten (me~/mr ') mice also develop the so-called autoimmune diseases characterized by patchy alopecia (hence the name) (9, 10), inflamed paws (11), and hypergammaglobulinemia (12). Typically, their serum has high titers of autoreactive antibodies (9-13), and immune complexes are present in various tissues, such as the skin, lung, and kidney (10). The mutant animals died prematurely, usually of pneumonitis characterized by the accumulation of macrophages, lymphocytes, and granulocytes in the lungs (10, 14) .
p rotein tyrosine kinases and phosphatases play a major role in protein tyrosine phosphorylation, a process that regulates cell growth and proliferation. Some understanding of the physiological role of particular protein kinases and phosphatases can be inferred from the phenotype of mutant animals. In the case of hematopoietic cell phosphatase (HCP) l (1) (2) (3) (4) (5) , which is deficient in mice homozygous for the motheaten (me~me) mutations (6--8) , the mutant phenotypes have been intensively studied. The me~me mice and the allelic me"/me ~ mice are severely immunodeficient. In both motheaten mutants, maturations of B and T lymphocytes are impaired. Both me~me and viable motheaten (me~/mr ') mice also develop the so-called autoimmune diseases characterized by patchy alopecia (hence the name) (9, 10) , inflamed paws (11) , and hypergammaglobulinemia (12) . Typically, their serum has high titers of autoreactive antibodies (9) (10) (11) (12) (13) , and immune complexes are present in various tissues, such as the skin, lung, and kidney (10) . The mutant animals died prematurely, usually of pneumonitis characterized by the accumulation of macrophages, lymphocytes, and granulocytes in the lungs (10, 14) .
Since systemic autoimmune diseases usually result from complex interactions among lymphoid (B and T) cells and target tissues, it is difficult to distinguish the contribution of 1Abbreviations used in this paper: HCP, hematopoietic cell phosphatase; me/ me, motheaten mice; me~/me ~, viable motheaten mice; RAG-l, recombination activation gene-1; SSCP, single-strand conformation polymorphism. 371 each cell type in the initiation of the autoimmune response and the induction of specific pathological lesions. The presence of lymphocytes and complexes in affected tissues in both motheaten mutants has suggested that the immune system might contribute importantly to the motheaten phenotype. This hypothesis predicts that the motheaten phenotype will be alleviated by disruption in the recombination activation gene-1 (RAG-l), a null mutation that prevents V(D)J rearrangement and thus prevents development of antigen specific B and T cells (15) . To test this prediction, we generated and studied double-mutant mice, meV/me v RA G-1 -/-. The me v/me v RA G-1 -/-mutant mice develop disease characteristic of the motheaten phenotype, including pneumonitis, inflammation of the skin and extremities, and splenomegaly with elevated myelopoiesis. Thus, except for autoantibodies, all manifestations of the motheaten disease occur in the absence orB and T cells.
Materials and Methods
Mice. The founding C57BL/6J +/me ~ mice were obtained from The Jackson Laboratory (Bar Harbor, ME), and the founding RAG-1 -/-mice were kindly provided by S. Tonegawa (Massachusetts Institute of Technology, Cambridge, MA). Mice were maintained at the animal facility of the Ontario Cancer Institute (Toronto), and kept in microisolator housing units (Lab Products, Maywood, NJ) in rooms equipped with the Hepafiltered air handling system. Cages, bedding, and water were sterilized by autoclaving, and food was sterilized by ",/-irradiation. Mice were handled by aseptic forceps or aseptic gloves. loci), the R A G -1 i control mice (i.e., mice that are homozygous for the RAG-1 null mutation and have at least one wild-type allele at the me ~ locus), the m e " / m e ~ control mice (i.e., mice that are homozygous for the me" mutation and have at least one wild-type allele at the RAG-I locus), and the double-mutant mice (i.e., mice that are homozygous for both the me ~ mutation and RAG-1 null mutation).
G e n e t i c T e s t i n g .
The strategy used for typing the m e v locus was to amplify the region of the genome containing the me" mutation by P C R and then to examine the amplified products by single-strand conformation polymorphism (SSCP) analysis. The primers used for amplifying a 167-bp fragment in which the m e v mutation is located were 5 ' -T G T C A T C G T C A T G A C T A C C -3 ' and 5 ' -T C A G G C T T G G C A G C A A A C T C G -3 ' . The latter primer was kinased with [33p]ATP. P C R conditions used were 15 s at 94~ 15 s at 54~ and 15 s at 72~ for 30 cycles. The amplified products were then subject to SSCP analysis: a portion of the P C R product was boiled for 3 rain, quickly chilled on ice, loaded on an M D E (J.T. Baker Chemical Co., Phillipsburg, NJ) gel, and run at 3 W for 19 h. The gel was dried, and the D N A was visualized by autoradiography.
The R A G -1 locus was typed by P C R of the region of the gehome containing the disruption in RAG-1. The primers used for amplifying an 809-bp RAG-I fragment present only in the wild-type Statistical Analysis. The statistical significance of differences $Survival analyses indicate that the double-mutant and the meVme" control do not differ significantly in the probability of survival at any given time (see Fig. 3 ). ~Difference between the mev/me v control and double-mutant is not significant (P = 0.299 in Fisher's exact test). IIDifference between the mev/me ~' control and double-mutant is significant (P = 0.047 in Fisher's exact test). 82 scored abnormally if they contained one or more of the three pathological characteristics, i.e., inflammation, intraalveolar erythrocytes, and M~ with crystalline material. **Difference between the meVme ~ control and double-mutant is significant (P = 0.038 in Fisher's exact test). **Difference between the me'~me ~ control and double-mutant is significant (P = 0.006 in Fisher's exact test). 55Splenomegaly was scored by visual inspection.
allele were 5 ' -A T C T C C T G C C A G A T A T G C G A A -3 ' and 5'-AAC-C T C T T C G A A T G G T A T C T -3 ' . The primers used for amplifying a 477-bp neo fragment present only in the RAG-1 disrupted allele were 5 ' -A T G A T T G A A C A A G A T G G A T T G C -3 ' and 5 ' -T C C -A G A T C A T C C T G A T C G
between sample means was based on Cox regression analysis (for survival analysis), chi square (X 2) test (for genotype analysis), and Fisher's exact test (for all other analyses). In all tests, differences are treated as significant when P <0.05.
Results

Generation and Analysis of Mutant Mice.
The breeding scheme and designation of the various control mice are described in Fig. 1 . We analyzed 30 informative litters. The genotype of each mouse was determined by DNA PCR and SSCP analysis for the me v locus and by PCR for the RAG-1 locus (Fig. 2 a) . When mice were killed, the genotypes were verified by flow cytometry, analyzing spleen cells with antibodies recognizing the IgM heavy chain (be), CD4, CD8ci, and Mac-1 (Figs. 2 b and 6 e) . Litter sizes ranged from 1 to 12, and the frequencies of the various genotypes were not significantly different from the expected Mendelian frequencies, i.e., 0.150 of the mice were me'~me ~ control (expected frequency --0.149, n = 107, X 2 P >0.900), and 0.194 of the mice were double mutant (expected frequency = 0.155, n = 160, X 2 P >0.250). The expected frequencies are calculated by taking into account of the various types of crossing that were carried out to generate a given genotype. For example, double-mutant mice were obtained from three types of crossing (see Fig. 1 Each mouse was also examined for characteristics normally present in mice defective in HCP: shortened life span, dermatitis, inflammatory lesions in the extremities, hemorrhagic pneumonitis, and extramedullary myelopoiesis sites. The median hfe span of the double mutants (97 d) was similar to that of the meV/me ~ control (72 d) but substantially shorter than that of the RAG-1 -/ control (190 d) and normal control (>275 d) ( Table 1) . By using the proportional hazard model and Cox regression analysis ( Fig. 3 and reference 17) , which take into account the mice that were alive, killed, and dead at the end of the study, we are able to conclude that the absence of RAG-1 expression does not significantly affect the probability of survival of the meg'~me v mice at any given time.
Dermatitis in me"/meV'RAG-1 /-Mice.
Severe dermatitis with patchy alopecia is the hallmark of the motheaten phenotype (9, 10). Both the meV/me ~ control and doublemutant mice in our study manifested the disease with ruffled, "spotty" fur, indicating irregular hair growth (Fig. 4  a-d) . 9 out of 23 double-mutant mice and 8 out of 13 meV/ me v control mice had these skin lesions (Table 1 ). Since the frequency of skin lesions in the double mutant is not significantly different from that in the me"/me ~ control, the skin lesions in the me"/me v mice are not caused by B or T cells. given time, the probability of survival of the double-mutant is not significantly different from that of the md'/me ~ control (P >0.540). However, the probability of survival of the double mutant is significantly lower than that of the RAG-1 -/-control (P <0.001) and the normal control (P <0.001). There is weak evidence of a difference in the probability of survival between the RAG-1 -/-control and the normal control (P >0.070).
Inflammatory Lesions in the Extremities.
Both the meV/me ~ control and double-mutant mice developed the characteristic inflammation in the paws: extensive swelling and open pustular lesions. The paw lesions typically appeared between 5 and 10 d after birth, and the severity of these swellings and lesions was of the same magnitude (Fig. 4, e-g ). The frequencies of paw deformities in the meV/me v control (11 of 13) and double-mutant mice (19 of 29) were similar ( Table 1 ). The reason for incomplete penetrance of these symptoms is unknown, but may be caused by a variation in the time of onset of the disease.
Lung Abnormalities.
Lung abnormalities characteristic of pneumonitis were present in N70% of the meV/me ~ control and in all double-mutant mice examined (Table 1) . These pneumonitis-like characteristics were the likely cause of death of these mice during the first few months of life (Table 1 and Fig. 3 ). Histological analysis revealed severe inflammation in the lungs of both me~/me v control and double-mutant mice (Table 1 and Fig. 5 c-e) . A proportion of the normal control and RAG-I -/-control mice had some inflammation (Table 1) , but it was a much milder form than that in the lungs of the meP/me v control and doublemutant mice (Fig. 5, a and b) . A large amount of crystalline material, which appears to be associated with degradation of erythrocytes (10), is present inside the alveolar macrophages of the double-mutant mice. This abnormality has also been observed by Shultz (10) , who reported crystalline material in macrophages in the C57BL/6J meV/me v mice. The reason for their absence in the meV/me ~ control in the present study is unknown. Since the meV/me v control mice in our study are of a mixed genetic background (see Fig. 1 ), however, strain-specific factors may modulate the severity of the lung abnormalities. No crystalline material was detected in the lung sections of the RAG-1 -/-control or normal control (Table 1) . These results lead to the conclusion that in the absence of B and T cells, meV/me v mice develop severe hemorrhagic pneumonitis.
ExtramedullaryMyelopoiesis.
Elevated myelopoiesis in the spleen of the C57BL/6 meV/me v mice results in splenomegaly (10) . In the present study, the incidence of splenomegaly was similar in the me"/me v control and doublemutant mice (Table 1 ). The spleens of these mice generally had no organized white pulp (Fig. 6 a-d) and contained more than fivefold higher numbers of myeloid cells, as detected by anti-Mac-1 antibody, than the normal control and RAG-1 -/-control mice (Fig. 6 e) . 
Discussion
Since the R A G -I mutation used in the present study completely and specifically blocks the development of B and T cells, our results indicate that except for the production of autoantibodies, the manifestations of the m o t h e a t e n inflammatory disease occur in the absence of the antigenspecific arm of the i m m u n e system. Contrary to our findings, Shultz and Sidman (18) reported that the m e " / m e v s c i d / scid mice had a threefold increase in life span as compared to the m e " / m e v mice. This difference in life span might be because the effects of the scid mutation are not limited to B and T cells (19, 20) . Moreover, earlier studies using mouse mutations that partially block either B or T lymphopoiesis are consistent with our analysis of the completely B-and T-deficient m e V / m e V ' R A G -1 -/ -mutant mice. Scribner et al. (21) and Shultz (14) observed that neither the presence of the x i d mutation, which impairs the production of ease are not k n o w n . Infiltration of the affected mouse organs by monocytes, macrophages, and granulocytes suggest that these cell types are the primary effectors of inflammation in the m e V / m e v m i c e . Consistent with this n o t i o n is the observation that treatment with an antibody against CD1 lb, a subunit of Mac-1 whose expression is restricted to m o n onuclear phagocytes, granulocytes, and N K cells (26, 27) inhibits inflammation in m e v b o n e marrow chimeric mice (11) . Since the N K cells of m e v mice have virtually no activity and are present at only 30-50% of the normal levels (28), the C D 1 1 b study suggests that myeloid cells are responsible for the inflammatory disease of the m e~m e mice (11) . Cells of nonhematopoietic origin may also contribute to the m o t h e a t e n diseases. Although H C P is expressed p r e d o minantly in b o n e marrow, thymus, and hematopoietic cell lines (3, 4, 29) , it is detected in low abundance in a few epithelial cell lines and nonhematopoietic cancer cell lines (4, 29) . Mutating H C P in a cell-specific m a n n e r should delineate the cell types that are important in the manifestation of the m o t h e a t e n disease. 
